As the trend for increased transparency within the life sciences industry accelerates, it is accompanied by a vigorous debate about how to best achieve the goals of transparency. While some governments have adopted legislatively-imposed reporting requirements, other countries (and, in some instances, regions) rely on requirements created by industry associations. There is an obvious tension between these two approaches: supporters of transparency legislation claim that their model will result in cost savings and a reduction in corruption, whereas advocates of industry self-regulation emphasize that their approach is more efficient and could lead to global uniformity across borders.
The trend toward more transparency, and the fight between supporters of governmental action and advocates of industry self-regulation, is occurring throughout the world. This article will touch upon some of the global “hot spots” and highlight some recent developments.
Please click here to read the full white paper.